| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC1099 |
| Trial ID | ISRCTN11885863 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19|CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GC197 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Investigating the safety and efficacy of a Universal CAR-T cell immunotherapy in patients with relapse and refractory B-cell acute lymphoblastic leukemia and B lymphoblastic lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Gracell Biotechnologies Co., Ltd |
| Cohort 1 | |||||||||
|
|||||||||